Skip to main content
S 2338 113th Congress Senate Sports and Recreation Athletes Drug, alcohol, tobacco use Olympic games

United States Anti-Doping Agency Reauthorization Act

Introduced: May 14, 2014 See on congress.gov
 Everywhere this bill has been 17 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 18, 2014
Became Public Law No: 113-280.
Dec 18, 2014
Signed by President.
Dec 17, 2014
Presented to President.
Dec 12, 2014
Motion to reconsider laid on the table Agreed to without objection.
Dec 12, 2014
On passage Passed without objection. (text: CR H10314)
Dec 12, 2014
Passed/agreed to in House: On passage Passed without objection.(text: CR H10314)
Dec 12, 2014
Mr. Flores asked unanimous consent to take from the Speaker's table and consider.
Dec 12, 2014
Considered by unanimous consent. (consideration: CR H10314)
Dec 12, 2014
Received in the House.
Dec 12, 2014
Message on Senate action sent to the House.
Dec 11, 2014
Passed Senate without amendment by Unanimous Consent. (consideration: CR S6697; text as passed Senate: CR S6697)
Dec 11, 2014
Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.(consideration: CR S6697; text as passed Senate: CR S6697)
Dec 1, 2014
Placed on Senate Legislative Calendar under General Orders. Calendar No. 608.
Dec 1, 2014
Committee on Commerce, Science, and Transportation. Reported by Senator Rockefeller without amendment. With written report No. 113-281.
Sep 17, 2014
Committee on Commerce, Science, and Transportation. Ordered to be reported without amendment favorably.
May 14, 2014
Read twice and referred to the Committee on Commerce, Science, and Transportation.
May 14, 2014
Introduced in Senate
 Plain-English summary Congressional Research Service

(This measure has not been amended since it was introduced. The summary of that version is repeated here.)

United States Anti-Doping Agency Reauthorization Act - Amends the Office of National Drug Control Policy Reauthorization Act of 2006 to: (1) authorize appropriations for the U.S. Anti-Doping Agency for FY2014-FY2020, (2) require that the Agency be recognized worldwide as the independent national anti-doping organization for the United States, and (3) replace the Agency's role in preventing the use by U.S. amateur athletes of performance-enhancing genetic modifications accomplished through gene doping with a role in preventing the use of prohibited performance-enhancing methods adopted by the Agency.

What's happening now December 18, 2014

Became Public Law No: 113-280.

 Committees of jurisdiction 1